Global stock markets began the week on a sour note, with widespread declines fueled by renewed concerns over Federal Reserve interest rate policies and surging oil prices. The developments have reignited inflation worries and rattled investor confidence, leaving both Wall Street and international markets in the red.

Wall Street Extends Losses

U.S. markets looked set to continue Friday’s downward spiral, with futures on the S&P 500 and Nasdaq 100 sliding 0.7% and 1%, respectively, during premarket trading. High-profile technology stocks, including Tesla Inc., Palantir Technologies Inc., and Nvidia Corp., led the retreat, adding to last week’s steep losses.

The selloff comes on the heels of a stronger-than-expected U.S. jobs report that drastically reduced expectations for Federal Reserve interest-rate cuts in 2025. The report pushed traders to price in fewer than 30 basis points of rate reductions for the year, sparking a broader market slump.

European and Global Markets Feel the Pinch

European shares mirrored the U.S. decline, falling 0.8%, with technology stocks among the hardest hit. Markets globally have struggled to find their footing amid economic uncertainty, with the S&P 500 erasing its year-to-date gains and the Bloomberg Dollar Index climbing to two-year highs.

Sector Spotlight

Quantum Stocks Slide

Quantum computing stocks suffered heavy losses after Mark Zuckerberg, during a Friday appearance on the Joe Rogan Experience, echoed Nvidia CEO Jensen Huang’s view that quantum computing is still a decade away from practical application.

• Rigetti Computing: Fell 25%
• D-Wave Quantum: Dropped 16%
• IonQ: Declined 8%
• Quantum Computing Inc.: Lost 9%

Managed Care Stocks Buck the Trend

Managed care stocks were a rare bright spot. Shares of Humana, UnitedHealth, and CVS Health rose after the U.S. government proposed an average 4.3% increase to 2026 Medicare Advantage reimbursement rates. Humana gained nearly 6%, while UnitedHealth and CVS Health added 3% each.

Crypto-Linked Stocks Decline

Stocks tied to cryptocurrency saw declines as bitcoin’s price slipped to around $90,000. Key movers included:

• Coinbase: Down 4%
• MicroStrategy: Fell 4%
• Mara Holdings: Lost 4%
• Core Scientific: Retreated by 3%

Retail: Macy’s Struggles

Macy’s shares fell 2% after the company provided a disappointing update to its fourth-quarter guidance. The retailer expects revenue at the lower end of its $7.8 billion to $8.0 billion range, with comparable sales expected to remain flat.

Megacap Tech Stocks Under Pressure

Rising U.S. Treasury yields weighed heavily on megacap tech stocks. Losses included:

• Nvidia, Tesla, and Palantir Technologies: Down ~3% each
• Broadcom and Micron Technology: Shed ~2% each

Moderna Plunges

Biotech giant Moderna saw its shares plummet 20% after slashing its 2025 sales guidance by approximately $1 billion. The company cited significant headwinds, projecting 2025 revenue between $1.5 billion and $2.5 billion, with most sales expected in the latter half of the year.

With inflationary pressures back in focus and interest-rate policy uncertain, global markets face a challenging road ahead. Investors are closely monitoring oil prices, economic data, and central bank commentary for clues about the direction of the global economy.